Whole Genome Sequencing Cost and Self-Pay Testing Options

Clinical laboratory image related to Factor V Leiden Cost and Self

Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.

Whole genome sequencing cost has fallen enough that many people can now buy a 30x genome test online for a few hundred dollars. The hard part is figuring out what that price actually includes, whether a subscription or report fee is required, and whether the result will be useful for your specific health question.

Quick Take

  • Typical consumer self-pay range: about $299–$895 for many publicly priced 30x whole genome sequencing (WGS) options, depending on reports, subscriptions, and turnaround time.
  • Lowest advertised prices are not always lowest total cost. A $299 kit can become less attractive if ongoing membership is required for report access or updates.
  • Clinical diagnostic WGS is different. Tests ordered by a physician or genetic counselor for suspected disease often use insurance billing or a lab-specific self-pay quote rather than a simple checkout price.
  • Consumer WGS is not a substitute for diagnosis. Important findings should be reviewed by a qualified clinician and may need confirmation before medical decisions.
  • Best value depends on your goal: raw data ownership, medically oriented reporting, family planning, pharmacogenomics, rare-disease evaluation, turnaround time, privacy controls, or long-term reinterpretation.

Whole genome sequencing cost comparison

For this comparison, “effective cost to the patient” means the minimum publicly advertised price a U.S. consumer would expect to pay to receive sequencing and the core deliverables described by the provider, including mandatory kit or account fees when those were stated. Optional add-ons such as faster processing, premium reports, family kits, or ongoing annual memberships are listed separately instead of being used to rank providers.

Provider / option Advertised self-pay cost What the price appears to include Fees or caveats to check before ordering
Nebula Genomics / DNA Complete $299 for 30x WGS advertised on Nebula’s WGS page 30x whole genome sequencing and analysis, according to Nebula’s consumer page, which states that WGS covers the complete genome, mitochondrial DNA, and Y chromosome when present. Nebula’s WGS page Read the membership terms carefully. Nebula’s own page discusses a subscription, and separate DNA Complete terms describe membership pricing and billing rules. Check current turnaround-time and customer-service patterns before buying. DNA Complete terms
SelfDecode 30x WGS $399 for 30x WGS kit; higher bundles advertised at $1,499–$1,999 30x sequencing, kit, lifetime access language, and raw data downloads are described on SelfDecode’s WGS page. SelfDecode WGS page Some report packages cost extra. A SelfDecode help article also states that practitioner workflows may require a $25 client profile fee in addition to the $399 sequencing kit. SelfDecode WGS pricing help article
Sequencing.com $399 Standard bundle; $799 Professional bundle 30x WGS, health analyses, reports, raw data access in FASTQ/BAM/VCF formats, and free worldwide shipping are described on the company’s bundle page. Sequencing.com WGS bundle page Regular lab processing is included; expedited processing is listed at +$50 and ultra-rapid processing at +$200. Optional subscription or AI/report products should be separated from the base kit cost.
Human Longevity, Inc. Genomics for All $599 one-time price 30x clinical-grade WGS, physician-ready PDF report, pharmacogenomics, disease-risk insights, lifetime data access, and a 1-year HLI AI App subscription are listed on HLI’s genomics page. Human Longevity Genomics Check what happens after the included 1-year app period, how reanalysis is delivered, and whether a clinician is available if a result needs follow-up.
Level Genomics Starting at $599 for 30x WGS 30x WGS through a CLIA-certified, CAP-accredited lab partner, raw data downloads, free shipping, and 2–3 week stated turnaround. Level Genomics The page states results are for informational use. Confirm whether any interpretation layer, research assistant, or higher-depth option adds cost.
Mosaic Biodata $895 one-time bundle 30x WGS plus a Genomic Lifestyle Optimization Report, no subscription language, raw genome ownership, and clinical lab partner accreditations. Mosaic shop page More wellness/lifestyle oriented than a rare-disease diagnostic test. Confirm what medical or pharmacogenomic reporting is included before buying.

Some active WGS companies make price or checkout details hard to confirm without an interactive cart. For example, Dante Labs’ current WGS page describes 30x genome testing, core reports, raw data, free global shipping, and 6–8 week results, but the accessible public page did not display a specific dollar price in the comparison table at the time reviewed. Dante Labs genome page Nucleus describes 30x WGS, cheek-swab collection, prepaid return mailing, 4–6 week results, and a membership model; its shop page also states that samples are not accepted from within New York State, but some price fields are dynamically rendered. Nucleus Health Nucleus shop page

Why whole genome sequencing prices differ so much

The cost of sequencing a human genome has dropped dramatically since the Human Genome Project, but the consumer price is not just the lab’s reagent cost. The National Human Genome Research Institute explains that sequencing-cost estimates depend on technology, quality targets, analysis, and how costs are counted. NHGRI’s sequencing cost fact sheet

When you buy WGS, you are paying for several layers:

  • Sample collection: saliva or cheek-swab kit, shipping, accessioning, and sample quality checks.
  • Sequencing: the lab process that reads your DNA. Most consumer health WGS uses short-read sequencing at about 30x average coverage.
  • Bioinformatics: alignment to a reference genome, variant calling, quality filters, file generation, and sometimes structural-variant or copy-number analysis.
  • Interpretation: the reports that translate variants into health, trait, ancestry, carrier, or medication-response information.
  • Storage and updates: long-term hosting of large files, reanalysis as knowledge changes, and app or AI features.
  • Clinical support: physician ordering, genetic counseling, confirmatory testing, and insurance billing support, when available.

A low kit price may be a good deal if you mainly want raw data. It may be less useful if you need a clinician-ready report, genetic counseling, or clear follow-up pathways. Conversely, a higher-priced bundle may be reasonable if it includes reports you would otherwise buy separately, but only if those reports match your health question.

Self-pay WGS testing options

1. Consumer WGS for raw data and broad health reports

This is the most common online self-pay route. You order a kit, collect saliva or a cheek swab at home, mail the sample, and receive web-based reports plus raw files. Consumer providers often advertise 30x WGS, disease-risk reports, carrier status, pharmacogenomics, ancestry, nutrition, fitness, or longevity insights.

Choose this route if your goal is broad learning, data ownership, or long-term reanalysis. Do not choose it as a shortcut around medical genetics if you have a strong personal or family history of a serious inherited condition. A physician or genetic counselor can help choose a test that fits the suspected condition and interpret uncertain or unexpected findings.

2. Consumer WGS with medically oriented reports

Some providers emphasize “physician-ready” or “clinical-grade” reports. This can make the result easier to discuss with a clinician, but wording matters. “Clinical-grade sequencing” usually refers to laboratory quality or coverage; it does not automatically mean the report is accepted as a diagnosis, ordered for your medical indication, or covered by insurance.

If a provider reports hereditary cancer risk, cardiovascular variants, pharmacogenomics, or ACMG secondary findings, check whether the report clearly states the gene, variant, classification, evidence, limitations, and recommended confirmation steps. The American College of Medical Genetics and Genomics maintains guidance on reporting medically actionable secondary findings in clinical exome and genome sequencing; consumer reports may borrow this concept but may not follow the same clinical workflow. ACMG policy statements

3. Clinician-ordered diagnostic WGS

Clinical diagnostic WGS is usually used when a healthcare professional suspects a genetic condition, especially in rare disease, neurodevelopmental conditions, congenital anomalies, complex pediatric presentations, or situations where earlier panels and exome tests did not find an answer. These tests may include trio testing, where the patient’s genome is compared with both biological parents.

Clinical labs such as GeneDx and Variantyx describe insurance billing, self-pay options, financial assistance, and provider-order workflows, but they generally do not present WGS as a simple consumer checkout product. GeneDx states that only licensed healthcare providers can order testing directly, and it lists Genome Medical as an option for patients who need help connecting with a provider. GeneDx billing and ordering information Variantyx states that it offers self-pay pricing when a patient lacks U.S.-based insurance or coverage, and it notes that some Medicaid or managed Medicaid plans may not allow certain genome-wide tests as first-line testing in some states. Variantyx billing information

Expect clinical WGS to cost more than consumer WGS when paid fully out of pocket. Published health-economic reviews have found wide cost ranges for diagnostic genome sequencing because studies count different components, such as counseling, analysis, interpretation, trio testing, and downstream care. One review of genomic sequencing microcosting found genome sequencing estimates ranging from about $2,094 to $9,706 per patient. Microcosting diagnostic genomic sequencing review

Consumer WGS vs clinical WGS: the practical difference

Question Consumer WGS Clinical diagnostic WGS
Who orders it? Usually you order online, sometimes with behind-the-scenes physician authorization depending on the product. A licensed clinician orders it for a medical indication.
Main purpose Education, wellness insights, broad risk screening, pharmacogenomics, raw data access, longevity or trait reports. Diagnosis or evaluation of a suspected genetic disorder.
Typical self-pay price Often a few hundred dollars to under $1,000 for base WGS; more for premium reports. Often custom-quoted or billed to insurance; out-of-pocket cost depends on payer, indication, and lab policies.
Medical actionability Variable. Findings may need clinical confirmation and counseling. Designed for clinical interpretation and integration into care.
Family testing Usually separate kits; interpretation may not use formal trio analysis. May include duo or trio analysis, which can improve interpretation for rare disease.
Best fit Curious, informed consumers who understand limitations and want broad data. People with symptoms, abnormal exams, strong family history, or a clinician’s recommendation.

What WGS results can and cannot tell you

Whole genome sequencing reads far more DNA than a genotyping chip or targeted panel. That does not mean it gives perfect answers. A WGS report may find a pathogenic or likely pathogenic variant, a carrier finding, a medication-response marker, or a risk estimate based on many common variants. It may also find a variant of uncertain significance, often shortened to VUS, where current evidence is not enough to say whether the variant causes disease. MedlinePlus explains that VUS results can be difficult to interpret because evidence may be limited or conflicting. MedlinePlus on interpreting genetic test results

Important limitations include:

  • A negative WGS does not rule out all genetic disease. Some genetic changes are hard to detect with standard short-read WGS.
  • Risk is not destiny. Many common conditions depend on environment, lifestyle, age, ancestry, family history, and non-genetic factors.
  • Report quality varies. Two providers may interpret the same variant differently, especially for complex traits or emerging research.
  • Raw data can be misread. Third-party interpretation tools may overcall risk or use outdated variant classifications.
  • Family implications matter. A result may affect biological relatives, reproductive planning, or insurance concerns.

The FDA notes that direct-to-consumer tests have limitations and that a negative genetic health-risk result should not replace routine preventive care. FDA information on direct-to-consumer tests MedlinePlus also emphasizes that direct-to-consumer testing can provide useful information but may be incomplete for specific diseases or traits. MedlinePlus on DTC genetic testing benefits and risks

How to think about value, not just price

If two tests both advertise 30x WGS, compare the details that affect usefulness:

  • Raw data access: Can you download FASTQ, BAM/CRAM, and VCF files without extra fees?
  • Report scope: Are disease-risk, carrier, pharmacogenomic, and secondary-finding reports included or sold separately?
  • Mandatory membership: Is a subscription required to view results, maintain access, receive updates, or use the app?
  • Turnaround time: Is the stated timeline measured from order date, sample receipt, or lab acceptance?
  • Reanalysis: Are updates included once, annually, continuously, or only while subscribed?
  • Lab quality: Is the sample processed in a CLIA-certified and CAP-accredited lab, and is the test for informational or diagnostic use?
  • State restrictions: Does the provider accept samples from your state? New York often has stricter laboratory rules.
  • Support: Is genetic counseling, physician review, or customer support included?
  • Reputation patterns: Look for repeated complaints about delays, billing, subscriptions, refund difficulty, sample failures, or data access.

Public customer-satisfaction evidence is mixed across the WGS market. BBB pages and consumer-review sites can be useful for spotting patterns, not for proving whether a test is scientifically valid. For example, Sequencing.com’s BBB complaint page shows an accredited profile with complaints, including billing and service issues that the company has responded to in some cases. Sequencing.com BBB complaints Dante Labs’ BBB profile shows a poor rating and a pattern of unanswered complaints, which is a practical reason to verify recent turnaround and refund performance before ordering. Dante Labs BBB profile

Buying checklist before you pay

  1. Define your goal. Are you buying for curiosity, raw data, medication response, family planning, hereditary cancer concern, rare disease, or symptoms?
  2. Separate sequencing from interpretation. A low-cost kit may sequence your genome but charge extra for the report you actually want.
  3. Calculate the first-year total. Include kit, required profile fee, mandatory membership, shipping, expedited processing, and report add-ons.
  4. Calculate the three-year total. Include annual renewals if you want ongoing access or reinterpretation.
  5. Confirm state availability. If you live in New York, confirm sample collection and shipping rules before purchase.
  6. Read cancellation terms. Subscription, refund, failed-sample, and data-deletion policies matter as much as the advertised price.
  7. Check file formats. If you want independent analysis later, look for FASTQ plus BAM/CRAM and VCF downloads.
  8. Ask how clinically significant results are handled. Will the provider recommend confirmatory testing or clinician review?
  9. Do not stop screening or medication based on WGS alone. Use results as a starting point for a medical conversation.

When WGS may be worth paying for

Self-pay WGS may be reasonable if you want the most complete consumer genetic dataset available, understand uncertainty, and can afford follow-up if something important appears. It may also be useful if you have already done a genotyping-chip test and want more complete raw data for future interpretation.

WGS is less likely to be the right first purchase if you have one specific medical concern that is better evaluated by a targeted clinical test. For example, hereditary cancer, cardiomyopathy, connective-tissue disorders, or pharmacogenomic prescribing questions may be better served by a clinician-ordered panel that includes counseling, insurance documentation, and confirmatory workflows. In some cases, a $250–$500 focused clinical panel can be more actionable than a broad consumer WGS report.

Bottom line

The best whole genome sequencing cost is not simply the lowest advertised price. For many consumers, the realistic comparison is: $299–$399 for low-cost consumer WGS, $599–$895 for more bundled or clinically styled consumer WGS, and substantially more for clinician-ordered diagnostic WGS when paid without insurance. Before you buy, compare the effective total cost, what reports are included, whether ongoing fees apply, whether your state is supported, and how you will handle any medically important result.

 

FAQs

How much does whole genome sequencing cost?

Publicly priced consumer WGS commonly ranges from about $299 to $895 for 30x testing. Premium report bundles can exceed $1,000. Clinical diagnostic WGS ordered by a healthcare professional may cost much more, but final out-of-pocket cost depends on insurance, medical necessity, lab policy, and financial assistance.

Why is one WGS test $299 and another $895?

The difference usually reflects reporting, support, turnaround time, subscriptions, lab workflow, data storage, and reanalysis—not just sequencing. A cheaper test may be best if you want raw data. A higher-cost option may be better if it includes interpretation you would otherwise buy separately.

Is 30x WGS the same as clinical-grade WGS?

Not necessarily. “30x” refers to average sequencing depth. “Clinical-grade” may refer to lab standards, coverage, or marketing language. A test is clinically most useful when it is ordered for an appropriate indication, processed and interpreted under clinical laboratory standards, and reported in a way your healthcare team can use.

Will insurance pay for whole genome sequencing?

Insurance is more likely to consider WGS when it is ordered by a clinician for a documented medical indication, such as suspected rare genetic disease. Consumer wellness or longevity WGS is usually self-pay. Even when insurance covers testing, deductibles and coinsurance may apply.

Can whole genome sequencing find every disease risk?

No. WGS can detect many types of variants, but it cannot predict every disease, and many health conditions are not caused by a single gene. Some variant types require specialized tests, and many findings need clinical interpretation in the context of symptoms and family history.

What should I do if my WGS report shows a pathogenic variant?

Do not make major medical changes based only on a consumer report. Save the report and raw result details, then discuss them with a physician, genetic counselor, or relevant specialist. Confirmatory clinical testing may be recommended before the result is used for screening, surgery, medication changes, or family testing.

What if my result is a VUS?

A variant of uncertain significance is not the same as a positive result. It means current evidence is insufficient or conflicting. Most VUS findings should not drive medical decisions unless a genetics professional later reclassifies the variant based on stronger evidence.

Sources

Scroll to Top